title: Antioxidants. Do they have a place in the prevention or therapy of acute kidney injury?
abstract: Over the past several years, advances in our understanding of the pathogenesis of acute kidney injury (AKI) have demonstrated the role of oxidant stress and reactive oxygen metabolites (ROM) in the development of AKI in a variety of clinical settings. This review serves to define the pathways that lead to the generation of ROM following a variety of insults, as well as to review the current literature concerning the role of antioxidant therapy in the prevention and treatment of AKI in several clinical settings. Investigators have explored the potential therapeutic role of anti-oxidants in both experimental animal models and human studies of AKI in several clinical settings, including cardiac and aortic occlusive surgeries, sepsis, drug nephrotoxicity (cisplatin and gentamicin), as well as rhabdomyolysis. While the experimental animal studies have generally been more successful, taken together this literature supports the hypothesis that oxidant stress-induced production of ROM plays a major role in the pathogenesis of many forms of AKI, and continues to suggest the potential utility of antioxidant therapy in human AKI. Ongoing trials in concert with improved diagnostic techniques will hopefully lead to improved outcomes in the setting of AKI through the prophylactic or early therapeutic use of antioxidant therapy.
authors.affiliation: Section of Nephrology, Department of Medicine, University of Chicago, Chicago, Ill., USA.
authors.forename: Jay L
authors.initials: JL
authors.lastname: Koyner
authors.forename: Roshan
authors.initials: R
authors.lastname: Sher Ali
authors.forename: Patrick T
authors.initials: PT
authors.lastname: Murray
mesh_terms: D058186:Acute Kidney Injury / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control*; D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D001026:Coronary Artery Bypass / Q000009:adverse effects; D005839:Gentamicins / Q000009:adverse effects; D006801:Humans; D018384:Oxidative Stress; D012206:Rhabdomyolysis / Q000150:complications / Q000628:therapy; D018805:Sepsis / Q000150:complications
chemical_list: D000975:Antioxidants; D005839:Gentamicins